Indica Labs: Announcing HALO AI Apps for Life Science Image Analysis Workflows
The Breast IHC Cancer Cell Phenotyper App can be used in conjunction with other HALO AI Apps or HALO modules to derive additional quantitative outputs. In the example shown here, the Breast IHC Cancer Cell Phenotyper App is added to the Multiplex IHC module to measure biomarker intensity specifically in cancer cell nuclei (top row) and membranes (bottom row). The cell phenotype mark-up is in the middle column and in the third column, the Multiplex IHC module is used to assign a 0 to +3 intensity score to cancer cells specifically.
The latest from the Indica Labs blog:
[Indica Labs is] excited to announce the launch of HALO AI Apps, pre-trained tissue classifiers and cell phenotypers for tissue-based research applications in the life sciences. HALO AI Apps demonstrate powerful image analysis capabilities across a variety of tissue types out-of-the-box and can be further trained, tuned, and improved upon by customers with their own images and data. In total, 11 new apps are now available!
What Functionality Is Included?
While the Pan-Cancer H&E Lymphocyte Cell Phenotyper App works across a variety of cancer tissue types, the remaining 10 new products are designed for analysis of the following cancer types: breast, colorectal, gastric, ovarian, head and neck squamous cell, and non-small cell lung cancer (NSCLC). All HALO AI Apps can be applied to regions of interest, fields of view, or across entire whole slide images.
Where desired, customers can add additional training to the apps using easy-to-use annotation tools within the HALO AI interface. Furthermore, the apps are seamlessly integrated with HALO® image analysis modules. The Breast IHC Tumor Tissue Detection App, for example, can be integrated into the Multiplex IHC module to facilitate tumor–specific analysis of biomarker expression. In immuno-oncology research, the Pan-Cancer H&E Lymphocyte Cell Phenotyper App can be used with the Spatial Analysis module to investigate immune infiltration and spatial relationships between lymphocytes and cancer cells within the tumor microenvironment.
Where Can I Learn More?
The new life science apps are currently available for customers to trial and purchase individually. To learn more about HALO AI Apps and to see a live demonstration, register for Indica Labs’ upcoming webinar titled “Introducing HALO AI Apps for the Life Sciences” on Thursday, September 26, at 8:00 am PDT | 11:00 am EDT | 16:00 BST. Alternatively, reach out to info@indicalab.com to schedule a software demonstration or to trial of any of the following apps:
- Breast IHC Cancer Cell Phenotyper
- Breast IHC Tumor Tissue Detection
- CRC H&E Cancer Cell Phenotyper
- Gastric H&E Tumor Tissue Detection
- HNSCC H&E Tumor Tissue Detection
- NSCLC H&E Cancer Cell Phenotyper
- NSCLC H&E Tumor Tissue Detection
- NSCLC IHC Cancer Cell Phenotyper
- NSCLC IHC Tumor Tissue Detection
- Ovarian H&E Tumor Tissue Detection
- Pan-Cancer H&E Lymphocyte Cell Phenotyper
In addition, supporting materials are available on the HALO AI Apps page of the Learning Portal.
You will need a Learning Portal account to access these resources. If you do not already have an account, you can create one here.
Are There Any Installation Prerequisites?
HALO AI Apps and HALO modules are intended for research use only.
Prerequisites for the installation of HALO AI Apps include HALO and HALO AI 4.0.5 or later.
Questions?
If you have any questions regarding this release, feel free to reach out to support@indicalab.com.
